Genetics of Schizophrenia: Recent Advances
By Amy Eisener, BS, Michele T. Pato, MD, Helena Medeiros, MSW, Celia Carvalho, MS, and Carlos N. Pato, MD
Gender and Schizophrenia
By Carla M. Canuso, MD and Gahan Pandina, PhD
ORIGINAL RESEARCH
Financial Incentives to Improve Adherence to Medication in Five Patients with Schizophrenia in The Netherlands
By Anton B.P. Staring, C.L. Mulder, S. Priebe
By Laura B. Dunn, MD
Ethical Issues in Schizophrenia: Considerations for Treatment and Research
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
By John M. Kane, Christoph U. Correll, Grace S. Liang, Joshua Burke, Christopher F. O’Brien
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
By Christoph U. Correll, Richard C. Josiassen, Grace S. Liang, Joshua Burke, Christopher F. O’Brien
Effectiveness of Clozapine use in Delaying Hospitalization in Routine Clinical Practice: A 2 year Observational Study
By Kazare Nyakyoma, Richard Morriss